Exclusive: Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug


By Deena Beasley

LOS ANGELES (Reuters) – Express Scripts Holding Co (O:ESRX), one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly (N:LLY) and Amgen Inc (O:AMGN), but is excluding a rival medication made by Teva Pharmaceutical (NYSE:TEVA) Industries Ltd (TA:TEVA) after price negotiations with all three manufacturers. The decision represents a setback for Teva, which is in the midst of a corporate restructuring and had hoped to capture a sizable stake of the multibillion-dollar migraine market. Express Scripts is also taking steps to limit use to the patients it says are most likely to benefit from the new Amgen and Lilly migraine drugs.

Read more at : https://www.investing.com/news/stock-market-news/exclusive-express-scripts-covers-amgen-lilly-migraine-therapies-excludes-teva-drug-1647668